anticorps 1110037L13Rik, anticorps 9330105E13, anticorps VAT2, anticorps Vmat2, anticorps MNAT, anticorps VMAT-2, anticorps VMAT2, anticorps solute carrier family 18 (vesicular monoamine), member 2, anticorps solute carrier family 18 member A2, anticorps Slc18a2
Sujet
The vesicular monoamine transporter acts to accumulate cytosolic monoamines into synaptic vesicles, using the proton gradient maintained across the synaptic vesicular membrane. Its proper function is essential to the correct activity of the monoaminergic systems that have been implicated in several human neuropsychiatric disorders. The transporter is a site of action of important drugs, including reserpine and tetrabenazine (summary by Peter et al., 1993 [PubMed 7905859]). See also SLC18A1 (MIM 193002).[supplied by OMIM, Jan 2011],SLC18A2,SVAT,SVMT,VAT2,VMAT2,Neuroscience,Neurodegenerative Diseases,Dopamine Signaling in Parkinson's Disease,SLC18A2